Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to -$857000.0.

  • Mimedx's Cash from Financing Activities fell 327407.41% to -$857000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 8776.53%. This contributed to the annual value of -$34.2 million for FY2024, which is 29905.48% down from last year.
  • As of Q3 2025, Mimedx's Cash from Financing Activities stood at -$857000.0, which was down 327407.41% from -$1.1 million recorded in Q2 2025.
  • Mimedx's Cash from Financing Activities' 5-year high stood at $370000.0 during Q3 2023, with a 5-year trough of -$33.5 million in Q1 2024.
  • In the last 5 years, Mimedx's Cash from Financing Activities had a median value of -$359000.0 in 2024 and averaged -$2.7 million.
  • In the last 5 years, Mimedx's Cash from Financing Activities soared by 20000.0% in 2022 and then plummeted by 83657500.0% in 2024.
  • Quarter analysis of 5 years shows Mimedx's Cash from Financing Activities stood at $22000.0 in 2021, then surged by 200.0% to $66000.0 in 2022, then crashed by 13645.45% to -$8.9 million in 2023, then skyrocketed by 95.53% to -$400000.0 in 2024, then plummeted by 114.25% to -$857000.0 in 2025.
  • Its last three reported values are -$857000.0 in Q3 2025, -$1.1 million for Q2 2025, and -$2.9 million during Q1 2025.